Asian Pharmaceutical Stocks Drop as Trump Imposes 100% Tariffs
On Friday, shares of pharmaceutical companies in Asia saw a decline after President Donald Trump announced the imposition of hefty tariffs on specific goods, including pharmaceuticals.
Beginning October 1, Trump stated that all branded or patented pharmaceutical products will be subject to a 100% tariff unless the companies manufacture their drugs within the United States. This announcement was made via Trump's post on Truth Social.
Following the announcement, Japan’s Topix Pharma Index experienced a 1.39% reduction. Significant contributors to these losses were certain companies, which observed decreases of 3.34% and 2.18% respectively, along with another company falling by 3.03%.
South Korean pharmaceutical giants like Samsung Biologics and SK Bio Pharmaceuticals also faced setbacks, with their shares dropping by 1.66% and 2.66% respectively.
In Hong Kong, pharmaceutical stocks were among the biggest fallers within the Hang Seng Index, with the leading company experiencing a 2.95% plunge. Other companies were also down, registering decreases of 1.84% and 1.25% each.



Leave a Reply